The Enterprise Value as of December 2025 (TTM) for Zhejiang Medicine Co., Ltd. (600216.SS) is 11.42B

According to Zhejiang Medicine Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.42B. This represents a change of -4.99% compared to the average of 12.02B of the last 4 quarters.

Zhejiang Medicine Co., Ltd. (600216.SS) Historical Enterprise Value (quarterly & annually)

How has 600216.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Zhejiang Medicine Co., Ltd. over the last ten years is 11.45B. The current 11.42B Enterprise Value has changed 9.87% with respect to the historical average. Over the past ten years (40 quarters), 600216.SS's Enterprise Value was at its highest in in the June 2020 quarter at 18.75B. The Enterprise Value was at its lowest in in the December 2018 quarter at 6.69B.

Zhejiang Medicine Co., Ltd. (600216.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zhejiang Medicine Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zhejiang Medicine Co., Ltd. (600216.SS) Average Enterprise Value

How has 600216.SS Enterprise Value performed in the past?

The current Enterprise Value of Zhejiang Medicine Co., Ltd. (600216.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Zhejiang Medicine Co., Ltd. (600216.SS) Enterprise Value vs. Peers

How is 600216.SS’s Enterprise Value compared to its peers?

Zhejiang Medicine Co., Ltd.’s Enterprise Value is greater than Shanghai Shyndec Pharmaceutical Co., Ltd. (10.79B), less than Jiang Zhong Pharmaceutical Co.,Ltd (13.99B), less than Tibet Rhodiola Pharmaceutical Holding Co. (12.50B), less than Xiamen Kingdomway Group Company (11.49B), less than Henan Lingrui Pharmaceutical Co., Ltd. (12.24B), less than Guobang Pharma Ltd. (13.00B), less than Zhejiang Jingxin Pharmaceutical Co., Ltd. (15.77B), less than Zhejiang Hisun Pharmaceutical Co., Ltd. (14.15B), less than Pacific Shuanglin Bio-pharmacy Co., Ltd. (13.36B), less than CanSino Biologics Inc. (12.27B),

Build a custom stock screener for Zhejiang Medicine Co., Ltd. (600216.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Medicine Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Medicine Co., Ltd. (600216.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Medicine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.